3D Bioprinting Market to Surpass Valuation of US$ 6.5 billion by 2033 Owing to the Advancements in Tissue Engineering | Future Market Insights, Inc

3D Bioprinting Market to Surpass Valuation of US$ 6.5 billion by 2033 Owing to the Advancements in Tissue Engineering | Future Market Insights, Inc.
3D Bioprinting Market to Surpass Valuation of US$ 6.5 billion by 2033 Owing to the Advancements in Tissue Engineering | Future Market Insights, Inc.

Asia Pacific is the largest 3D bioprinting market. The 3D Printed Hip and Knee Implants Market is expected to grow at 7% CAGR during 2023 to 2033. The global 3D Printing Market is forecasted to surpass US$ 27.03 billion in 2023

NEWARK, Del: The global 3D Bioprinting Market is expected to create lucrative growth opportunities over the assessment period from 2023 to 2033 by registering a CAGR of 12.6%. The market is projected to hold a valuation of US$ 2 billion as of 2023. By 2033, the market is expected to be valued at US$ 6.5 billion. The historical CAGR for the global 3D bioprinting market was 12%. Owing to the high risk of peripheral vascular disease, diabetes, gangrene cases, and osteoarthritis amongst the geriatric population, we might witness an increase in the adoption of 3D bioprinting. According to the statistics released by World Health Organization, the world is rapidly aging at a fast pace. Between 2000 and 2050, the geriatric population is expected to surge from 11% to 22% worldwide. Manufacturers are working on 3D bioprinting multicellular vascular models over the assessment period.

There was significant demand for 3D bioprinting when the world was facing a shortage of skilled medical professionals across the flu period. These were particularly when there was a severe supply chain shortage. Thus, medical professionals were majorly relying on 3D printers and related software. Furthermore, numerous pharmaceutical companies are utilizing 3D bioprinting technology throughout the drug development process. The rapid adoption of 3D bioprinting enables pharmaceutical companies to test drugs at a lower cost. Moreover, 3D bioprinting allows pharmaceutical companies to test drugs within a few hours in comparison to a conventional method. Besides this, the application of 3D printing medical devices drastically reduces the usage of animals for drug testing.    

Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-808 

The favorable regulatory enforcements are anticipated to propel the sales of 3D bioprinting during the assessment period. the FDA in the USA has classified 3D-printed medical devices into Class I, Class II, and Class III devices. The classification of these devices has helped manufacturers to lay emphasis on the system to be manufactured based on the intensity of the disease. Throughout the valuation period, even surgeons might make use of 3D bioprinting technology on a consistent basis. This is attributed to the increasing demand for reconstructive surgery. Consequently, we might get to see the manufacturers focusing on bio 3D printing devices and related devices as a part of their manufacturing strategy.   

Key Takeaways 

  • The 3D cell culture method is an effective alternative to overcome the existing organ donation shortage crisis faced by the world. According to the U.S. Government Information on Organ Donation and Transplantation, more than 113,000 people are on the waiting list as of July 2019. The unavailability of organs for transplant cause the death of 20 patients per day. 
  • 3D bioprinting can be a significant solution to the organ transplant waiting crisis so that patients can receive an organ for transplant in time. 3D bioprinting technology has been used in regenerative medicine through printed devices such as 3D printing surgical instruments and prosthetics. Currently, researchers are testing out bio-ink as a way of printing cartilage, bones, and vital organs.
  • The ongoing research on regenerative medicine and advancements in tissue engineering are focusing on the regeneration of damaged tissues and organs with the help of 3D bioprinting. A group of scientists from Tel Aviv University developed a fully vascularized heart using 3D bioprinting by using fat tissue cells from a donor. This has led to the development of 3D bio-printed heart tissue. Scientists from Swansea University UK developed a 3D bioprinting process by using regenerative and durable biomaterial.  

Ask An Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-808 

Competitive Landscape 

The key players operating in the 3D bioprinting market are currently strengthening their materials portfolio. This is mainly done by adding new metals to the product portfolio. Apart from that, technological upgradation is also being done by the key players to simplify the processes.

More Insights into the 3D bioprinting market 

The Asia Pacific region is expected to dominate the global 3D bioprinting market over the assessment period. As per FMI analysis, developing economies like India, China, and Japan are expected to make massive contributions, owing to massive investment in the healthcare sector. Additionally, increasing disposable income is also expected to surge the market share in this region. 

China is expected to generate reasonable revenue in the global market since the Chinese government is offering to fund the establishment of a manufacturing facility for the production of biomaterials and studying 3D-printed organs and tissues. In 2015, Materialise NV. opened its first pediatric 3D medical research facility at the Children’s Medical Center, in Shanghai, China. The focus was on pediatric 3D modeling and medical imaging and 3D fabrication. 

Request Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-808 

Key Players

  • 3D Systems
  • GE Healthcare
  • ExOne
  • Electro Optical Systems 
  • Renishaw plc

3D Bioprinting Market Segmentation

By Technology:

  • Stereolithography,
  • Selective Laser Sintering,
  • Electron Beam Melting,
  • Fused Deposition Modeling,
  • Laminated Object Manufacturing,
  • Inkjet Printing,
  • Multi-phase Jet Solidification

By Application:

  • Surgical Simulation and Training Models,
  • Prosthetic Devices,
  • Tissue Engineering and Regenerative Medicine,
  • Orthopedic Implants,
  • Dental Implants,
  • Medical Sensors,
  • Others

By End User:

  • Medical Device Manufacturers,
  • Pharmaceutical Companies,
  • Research & Academic Institutions,
  • Contract Research Organizations

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

Get Full Access: https://www.futuremarketinsights.com/reports/3d-bio-printing-market 

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis 

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain

Medical Ventilators Market Size: According to FMI’s most recent market research, the global market for medical ventilators is predicted to reach US$ 1.7 billion in value by 2023. Between 2023 and 2033, the market is anticipated to grow at a 9.1% annual rate. The market is anticipated to reach $4 billion in sales by 2033.

Home Healthcare Market Share: The home healthcare industry is anticipated to reach a worth of US$ 3.2 billion in 2023 and is estimated to increase at US$ 4.4 billion by 2033. Throughout the projection period, it is predicted that the market will grow at a CAGR of 3.1%. The following list of market-size-influencing factors.

Intraocular Lymphoma Treatment Market Growth: By the end of 2023, the market for intraocular lymphoma treatments is expected to be worth US$ 1.2 billion. The market is anticipated to grow at a 6.7% CAGR through 2033 and reach a value of US$ 2.3 billion.

Kidney Transplant Market Demand: The market for kidney transplants is expected to reach a value of US$ 5.8 billion in 2022 and grow at a CAGR of 2.8% during the ensuing years. In 2022, a share of the global market for deceased-donor kidney transplants is expected to be at 74.7%, according to a new analysis by Future Market Insights.

Advanced Wound Management Market Opportunity: By 2023, the advanced wound management market is projected to be worth US$ 8.1 billion, and by 2033, US$ 11.5 billion may be the market valuation, according to FMI. Throughout the forecast period, the market is expected to grow at a CAGR of 3.6%.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, U.S., and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

LinkedInTwitterBlogs | YouTube

For Sales Enquiries: sales@futuremarketinsights.com


Please enter your comment!
Please enter your name here